Member Info for Brondby

Looks like gst hit resistance at 2p. Profits coming here by the look of things

In that case, I really find your dislike and vitriol for ciz quite strange, and can only imagine your expectations for what you thought might happen have so far not been met.

But realistically ciz is never going to rocket properly until the test is commercialised. It may cizzle a little, as it did back in March after some pumping. But I dont want pumpers here.

Keep it quiet, keep it cheap, accumulate as many as you are comfortable losing (nothing is certain after all), and wait....

And celebrate a huge life saving innovation in cancer detection when it comes.

You may be 80% down widdie, most of us aren't .

Appreciate your view, having bought very early in the journey, at a high price, you feel somewhat sore. But most folks on here, buying near the commercialisation of the test at much lower prices, and knowing the value of such a test, compared to our piddling valuation, feel somewhat differently.

And I'm not a ramper. I'm happy to see the price down here where I can buy cheap, at prices below our agreed loan facility! And when the RNS fnally drops, watch this rocket.

Widdie thats the way we want it. Keep it cheap and quietly buy more as impatient PIs sell up. Surprised you are still here TBH. Still that lingering doubt, eh?

Nobody wants it until everybody wants it. 👍

Really very little sign of extensive selling at all.

30p is a key resistance level so will take a while to break consistently. But #aet still very much on the uptrend.

Not the fastest mover, but long term uptrending shares very helpful in the current market.

just read this:

https://investors.bio-techne.com/strategy

"our "china for china" business has experienced strong double-digit growth"

"we see china as a continued growth driver for the company, with an expectation of revenue near $100 million in 3 to 5 years. we have added new leadership in the apac region, asia pacific and following a global subsidiary model we now have operations and managed distribution in virtually every couasia-pacific region."

and this:

https://d1io3yog0oux5.cloudfront.net/_c029084cf82dd62a5cfd6a1fff3fde02/biotechne/db/297/2492/pdf/2023+bio-techne+investor+day+presentation_final.pdf

"we are a global company

...

expand regional sales teams and offices in under-penetrated geographies, particularly in china, asia, and latin america"

"we are entering new categories through m&a identify fast growing and/or game changing technologies that can scale

integrate acquisitions that fill product or technology gaps

strengthen diagnostic and analytical capabilities that leverage our consumables portfolio

support continued expansion of footprint in europe and asia

extract maximum value from recent acquisitions

"

who do we know has a product much needed in china? 🤔

and with the above strategy, wouldn't someone get an utter ********** if they let a ciz slip through their hands, despite the test being on a biotechne platform?

all my opinion of course.

Neilin

You may (or may not :-)) be thinking along the same lines as me. But if a test on Biotechne's platform works well, with their global reach, why would they not want to own it outright? Ciz currently 6m mc. Biotechne $6b.

Bitechne fund remaining development with with right to buy ciz upon success at agreed price?

Just a thought

Chart suggests a rejection of lower prices. Weak hands out. And a gap to fill above. Onwards...

Joe, I hardly think the fortunes of an $8.5 billion company will be impacted by Allan's trip to China.

They missed EPS targets back in Spetember and price was falling in anticipating that since mid summer. Still on a downtrend.

Sounds like they need some great M&A acquisitions to turn the sentiment around 😉

Rigga. Cizzle doesnt need PIs (at least not until after the test is out and the institutions want to realise their profit, assuming ciz isn't bought out)

We should be grateful for the opportunity to buy at such low prices, and benefit from the long term hard work of Prof Coverley once the test is commercialised.

That would be fantastic dvharrison!

Market sentiment drives short term price, but also presents great opportunity.

Look at #tgr. Sub 14p and nobody wanted it. 1 month later its a bag and suddenly the market has decided its great after all. No substantive news, just some waffle about the broader market and China.

We're not at the bottom Joe. This will go lower.

Strap in. MM's can smell the SP weakness here.

Some good consolidation today and weak hands removed. Imagine being the guy that sold 500k shares at 1.73. Crazy IMHO.

Still, each to their own, and allowed me to buy under 1.8p. Would have preferred lower, but too many buyers stepping in so had to move in myself.

Settling in for the long game waiting for more bored PIs to sell up...

... for the cheap shares. Keep it up Wid Joe 👏

Took more at sub 1.80

Some bored PIs selling who think they can make a faster buck elsewhere.

MMs fishing for liquidity - drop the bid, see if anyone is spooked into selling, then sell them back for a quick profit. It'll keep happening until there is sustained buying pressure again.

Quite happy to see it drop. Can then buy more at lower cost.

See my post at 11.36 with dummy buy and sell quotes.

Suggests the biggie was a buy, and they were offering the highest sell price possible to try to fill it.

Very tight spread.

Buy for 0.145

Sell for 0.144

Let them sell for increasing low amounts.

Lets see the price down to 1.60p. Don't bail them out by buying now. Then we can add more cheaply. Let's have a clear out of weak hands.

Have patience and buy cheaply.

Or will it be "we've received an offer from Biotechne for 30p" before we ourselves know the clinical trials are started or complete.

ciz always very private about whay is going on. Comes from having no reliance at all on retail investmemt.

Someone just bought a wedge.